Conestat alfa
Ruconest (conestat alfa) is a protein pharmaceutical. Conestat alfa was first approved as Ruconest on 2010-10-28. It has been approved in Europe to treat hereditary angioedemas.
| Trade Name | Ruconest |
|---|---|
| Common Name | Conestat alfa |
| Indication | hereditary angioedemas |
| Drug Class | Enzyme inhibitors |
